Successful Treatment of Lymphomatoid Granulomatosis with Rituximab in a Kidney Transplant Patient
Author Information
Author(s): Cindy Castrale, Wael El Haggan, Françoise Chapon, Reman Oumedaly, Thierry Lobbedez, Jean Philippe Ryckelynck, Bruno Hurault de Ligny
Primary Institution: Caen University Hospital
Hypothesis
Can rituximab effectively treat lymphomatoid granulomatosis in renal transplant patients?
Conclusion
The patient achieved a complete disappearance of lymphomatoid granulomatosis after treatment with rituximab and has remained well for over four years.
Supporting Evidence
- The patient was diagnosed with lymphomatoid granulomatosis after a cerebral biopsy.
- Rituximab treatment led to a complete disappearance of symptoms and lesions.
- The patient has maintained good kidney function for over four years post-treatment.
Takeaway
A 70-year-old woman with a rare disease called lymphomatoid granulomatosis was treated with a medicine called rituximab, and it worked really well for her.
Methodology
The patient underwent a reduction in immunosuppression and was treated with rituximab, leading to significant clinical improvement.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
70-year-old female renal transplant recipient.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website